Pharma Industry Trend

In: Science

Submitted By bestjp
Words 354
Pages 2
The global pharmaceutical industry has enjoyed steady growth in recent years, despite a global economic downturn. But with patent expiries, stricter regulations, and U.S. healthcare reforms, the pharmaceutical industry is increasingly under pressure to maintain its steady revenue flow.

With the patent cliff looming through 2014, many pharmaceutical companies are restructuring to reestablish their industry dominance. They are reinventing themselves through mergers and acquisitions, or are signing licensing deals in order to survive.

Real Publishing presents a study of key pharma industry trends. This report offers an analysis of the impact of those trends, and reforms and regulations, particularly in the U.S. and the EU.

Key Trends Explored:

- Generic drug manufacturers are gearing up to take advantage of the opportunities presented by the many patent expiries

- What trends are impacting the leading generic drug manufacturers such as Teva, Sandoz, and others

- What government regulations and policies will effect pharma company bottomlines in 2012 and beyond?

- How are pharma companies using mergers and acquisitions to maintain a competitive edge?

- What is the state of the current global pharmaceutical industry and where is it growing?

- Pharmerging countries contribute approximately half of growth, with China as third-largest market

Global Pharma Industry Trends Examined:

- Challenge of Patent Expiries
- Challenges Facing the Generic Market
- Cost-savings with Generics
- Enforcing Prescription by INN
- Providing Incentives for Pharmacists
- Innovation in Existing Reference Pricing Systems
- Relation between U.S. Healthcare Reform and Generic Uptake
- Change Likely for U.S. Generics' Market Entry
- Pharmaceuticals and Biologics
- Tough Regulations in the EU
- Innovation by Generic Producers
- Impact of Price Cuts by…...

Similar Documents

Pharma Industry Trend

...The global pharmaceutical industry has enjoyed steady growth in recent years, despite a global economic downturn. But with patent expiries, stricter regulations, and U.S. healthcare reforms, the pharmaceutical industry is increasingly under pressure to maintain its steady revenue flow. With the patent cliff looming through 2014, many pharmaceutical companies are restructuring to reestablish their industry dominance. They are reinventing themselves through mergers and acquisitions, or are signing licensing deals in order to survive. Real Publishing presents a study of key pharma industry trends. This report offers an analysis of the impact of those trends, and reforms and regulations, particularly in the U.S. and the EU. Key Trends Explored: - Generic drug manufacturers are gearing up to take advantage of the opportunities presented by the many patent expiries - What trends are impacting the leading generic drug manufacturers such as Teva, Sandoz, and others - What government regulations and policies will effect pharma company bottomlines in 2012 and beyond? - How are pharma companies using mergers and acquisitions to maintain a competitive edge? - What is the state of the current global pharmaceutical industry and where is it growing? - Pharmerging countries contribute approximately half of growth, with China as third-largest market Global Pharma Industry Trends Examined: - Challenge of Patent Expiries - Challenges Facing the...

Words: 354 - Pages: 2

Indian Pharma Industry

...Indian Pharma Industry – an overview April 13, 2012 The demand for pharmaceutical products in India is significant and is driven by low drug penetration, rising middle-class & disposable income, increased government & private spending on healthcare infrastructure, increasing medical insurance penetration etc.    The Indian pharmaceutical industry is growing at about 8 to 9 percent annually according to “A Brief Report Pharmaceutical Industry in India,” published in January 2011. The Pharmaceutical industry in India meets around 70% of the country's demand for bulk drugs, drug intermediates, pharmaceutical formulations, chemicals, tablets, capsules, orals and injectables. There are approximately 250 large units and about 8000 Small Scale Units, which form the core of the pharmaceutical industry in India (including 5 Central Public Sector Units).    I. Current Scenario:    India's pharmaceutical market grew at 15.7 per cent during December 2011. Globally, Indiaranks third in terms of manufacturing pharma products by volume. According to McKinsey, the Pharmaceutical Market is ranked 14th in the world. By 2015 it is expected to reach top 10 in the world beating Brazil, Mexico, South Korea and Turkey. More importantly, the incremental market growth of US$ 14billion over the next decade is likely to be the third largest among all markets. The US and China are expected to add US$ 200bn and US$ 23bn respectively.     McKinsey & Company’s report, “India Pharma...

Words: 1969 - Pages: 8

Pharma

... March. Latvian News Agency. 2009 28 Januari 2009. Lithuania: Revised budget of 2009 after Easter Baltic Business News. 2009 12 April 2009. Saluse JaAA. Impact of taxation policy on pharmaceutical policy. 2008 October 2008;Health Policy Monitor. Industry Trend Analysis - Ministry Of Health Wrestling To Prevent Price Hikes BMI Industry Insights - Pharma & Healthcare, Emerging Europe. 10 June 2009. Thompson M. GP Visits and Other Medical Services to See Price Hike in Latvia from 2009 Global Insight Daily Analysis. 2008 13 October 2008. About the ATC/DDD system. 2009 29-09-2009 [cited 2009 02-12-2009]; Available from: www.whocc.no/atcddd/atcsystem.html IMF. World Economic Outlook Update: A Policy-Driven, Multispeed Recovery. January, 26 2010 [cited 18 February 2010]; Available from: http://www.imf.org/external/pubs/ft/weo/2010/update/01/index.htm Seputyte M. Baltic Countries to Remain in Recessions in 2010, Danske Says. BusinessWeek. 2010 17 February 2010. Simon Z, Brown, A. East Europe’s Recovery ‘Limps’ as Czech Slump Deepens (Update3). BussinessWeek. 2010 February, 12 2010. 53 References Impact of the economic recession on pharmaceutical consumption Annexes Annex 1: Correlation decline in GDP and pharmaceutical consumption ............................................. 55 Annex 2: Consumption of medicines with acute and chronic indication ............................................. 56 Annex 3: Consumption of original & licensed brands and others brands...

Words: 25253 - Pages: 102

Pharma

... The Omani Pharmaceutical Market ................................................................ 19 3. 4. 5. 6. 7. 8. GROWTH DRIVERS ............................................................................... 21 CHALLENGES........................................................................................ 27 TRENDS ............................................................................................... 31 PORTER’S FIVE FORCES MODEL ........................................................... 35 MERGER AND ACQUISITION (M&A) ACTIVITIES .................................. 36 MARKET OUTLOOK AND RECOMMENDATIONS ...................................... 38 COUNTRY PROFILES ......................................................................................... 41 COMPANY PROFILES ........................................................................................ 48 GCC Pharmaceutical Sector | March 31, 2013 Page | 3 “The pharma sector in Qatar is poised for growth over the next few years in line with the growth trend in GCC, which is the wider market segment. A major driver to this will be the projected growth in the economy. On the regulatory side, the recent legislation proposed by the Supreme Health Council towards deregulation of pharmaceutical imports to encourage free market competition is a step in the right direction. The industry is also looking forward to the proposed national health insurance program, as this is perceived to be a......

Words: 27542 - Pages: 111

How It Savvy Is the Pharma Industry?

...Individual Paper How IT Savvy is the Pharmaceutical Industry? [pic] How IT Savvy is the Pharmaceutical Industry? According to Peter Weill and Jeanne Ross, authors of the book, “IT Savvy: What Top Executives Must Know to Go from Pain to Gain”, IT Savvy firms need platforms of digitized processes that can make companies more agile and boost company performance. "The purpose of a digitized process platform is to disengage people from processes that are better performed by machines," the authors say. Therefore, that frees people up to focus on the key success drivers within the pharmaceutical industry, such as innovation and process excellence, which are embedded with dimensions of speed, quality, and decision making . My company The results obtained from the ‘How IT Savvy are you and your colleagues’ assessment showed the following: • The IT savvy score is 19.3, so the return we get per dollar invested in IT is above the industry average, in accordance with the assessment interpretation. There are still areas for continuous improvement. • The two major areas for implementing some enhanced processes are the cross -functional team shared experience and the simplification of business procedures. A real-life example of the previous topic regarding shared experience is the use of some customer service relevant data captured in one business area (market analysis) which is not taken into account throughout the company as an important tool to improve service...

Words: 1249 - Pages: 5

Indian Pharma Industry

... healthy growth rates, which could be attributed to the growth in penetration of healthcare in these markets. Key issues answered through this analysis: Which factors have impacted growth in regulated and semi-regulated markets? How have the changing global dynamics impacted share of large global pharmaceutical players in the pharma industry? Which are the drugs leading global pharmaceutical sales? How have different therapy classes grown over the past one year? Publish Date: 30-Oct-2012 | | Growth in regulated markets remains tepid, amid patent expiries, lack of new drugs  In 2011, global pharmaceutical sales (including audited and unaudited markets) grew by a modest 5.1 per cent y-o-y, to $956 billion (keeping the US dollar constant). Regulated markets such as the US, Europe and Japan continue to register slower growth, caused by expiry of additional drug patents and declining productivity of research and development activities, carried out by major pharmaceutical companies. Even as players witness a higher R&D cost, new drug approvals and filings have been on a declining trend. Trend in global pharmaceutical sales   * Using actual quarterly exchange rates Source: IMS Health Region-wise pharmaceutical sales (2011) Note: Includes both audited and unaudited markets. Sales cover direct and indirect pharmaceutical channel purchases in US dollars from pharmaceutical wholesalers and manufacturers. The figures above include prescription and......

Words: 12248 - Pages: 49

Pharma

...RESEARCH PROJECT ON “TRAINING AND DEVELOPMENT IN PHARMASUITICAL INDUSTRY WITH SPECIAL REFERENCE OF MANKIND PHARMA LTD” SUBMITTED IN PARTIAL FULFILLMENT OF DEGREE OF BACHELOR OF BUSINESS ADMINISTRATION SESSION (2011-2014) SUBMITTED TO: SUBMITTED BY: XYZ XYZ BBA III University Roll No. SUBMITTED TO ACKNOWLEGDEMENT “Gratitude is the hardest of emotions to express and one often does not find adequate words to convey what one feels and trying to express it” The present project file is an amalgamated of various thoughts and experiences .The successful completion of this project report would have not been possible without the help and guidance of number of people and specially to my project guide .I take this opportunity to thank all those who have directly and indirectly inspired, directed and helped me towards successful completion of this project report. I am also immensely indebted to my project guide, MS. Divya Vaid Lecturer, ICL, for his...

Words: 8569 - Pages: 35

Impact of Tqm on Indian Pharma Industry-Synopsis

... survey and review Quality Management Practices including ISO implementation in Indian Pharmaceutical industries. T1: A questionnaire will be designed and used to survey the Quality Management practices adopted in the Indian Pharmaceutical Industries. T2: The key Quality Management Practices will be reviewed for any shortcomings or deficiencies. O3: To identify and analyze the significant factors affecting Total Quality Management implementation in Indian Pharmaceutical Industries. T1: A pilot study will be conducted by using a sample questionnaire to identify significant factors which affect the implementation of Total Quality Management in select Pharmaceutical companies in Mumbai. T2: Based on the response and results of pilot study, the questionnaire will be modified and used to identify significant factors which affect the implementation of Total Quality Management in pharmaceutical companies across India. O4: To analyze the performance of Indian pharmaceutical Industries and compare with some major global pharma industries. T1: The performance of Indian Pharmaceutical Industry will be analyzed for financial performance, product quality, customer satisfaction, employee satisfaction, Market performance, Business results, cost and waste reductions, safety aspects. T2: The above parameters will be compared with equivalent parameters of global pharmaceutical industries to assess the relative standing of the Indian Pharmaceutical Industry. O5: To establish...

Words: 3769 - Pages: 16

New Trend of Digital Advertising in Auto Industry

...New trend of digital advertising in auto industry The earliest world known auto advertisement appeared in 1898. It was placed in a magazine called Scientific American occupying a whole page and cajoling reader to “dispense with a horse”. This very first auto ad was made for Winston Motor. We won’t see much Winston cars running these days since they stopped producing cars in 1924. I suspect at that time the Winston Motor couldn’t expect they set new era in motion. A century passed, auto ad has developed and grown. With the development of technology, there appeared more transmission channel. According to Borrell Associates’ latest report, the auto industry’s use of print, radio, and direct mail will be taken over by this growing transition to digital media. To put things into perspective, about 40 cents of every media dollar spent for automotive marketing will go toward digital advertising in 2011 and in 2012 it is likely 90% of additional advertising dollars will go toward digital media.[1]Obviously, digital media is the general trend in auto advertising. Television; internet website; social media network and video network are all digital platform. In this thesis I will focus on creative TV advertising; product placement and micro-film advertising. Because among all those digital ads, there are fast-growing recent years and represent the develop direction of automotive advertising. Creative TV commercials Most of the time, advertising is regarded as a...

Words: 3391 - Pages: 14

Pharma Industry and Market Value

...The Indian pharmaceutical market is highly competitive and remains dominated by low priced, domestically-produced generics. In value terms, India accounts for less than 4% of the world market and per capita expenditure on pharmaceuticals is relatively low. By 2010 end, the domestic Pharma market in India is expected to be US$ 13.76 billion and this is likely to increase at a compound annual growth rate of 9.5-10 per cent till the year 2015. The success and failure of any project in this industry is largely dominated by R&D spending. R&D spending of the large firms is almost as high as 10 percent of the total earnings. The aim of our study is to find out what effect R&D spending has on the market capitalisation as well as on the share prices of the firms. The regression technique along with the Booz-Allan-Hamilton approach has been used in finding out this relation. The Indian Pharmaceutical Market- A review India has a huge population in excess of one billion people and a growing middle class with access to high quality healthcare. The Indian pharmaceutical market is highly competitive and remains dominated by low priced, domestically-produced generics. In value terms, India accounts for less than 4% of the world market and per capita expenditure on pharmaceuticals is relatively low. The pharmaceutical sector is currently experiencing double digit growth and this is expected to continue, driven by the vaccines market. Continued growth is also expected in the...

Words: 484 - Pages: 2

Competition Law in Pharma Industry

...Competition Law & Pharmaceutical Industry Adithya Krishna Chintapanti About CENTAD Undertakes policy research and advocacy on issues related to trade and development, with a primary focus on South Asia. Centad’s work on access to medicines currently focuses on issues pertaining to access in India and aims to Secure a legal and policy environment to ensure access to medicines. Ensure transparency and accountability in public spending on drugs. Examine the impact of industry practices on access. Focus of the Presentation Bring to light anti-competitive practices prevalent in the pharmaceutical industry and healthcare sector. Indicate the approach proposed to be taken for executing the study and analyzing the data collected in pursuance thereof. Broad Scheme of Presentation Indian Pharmaceutical Industry a Snapshot Access to Medicines Situation in India Objectives of the Study Anti-competitive Practices Competition Act 2002 Regulation of Combinations Anti-competitive Agreements Abuse of Dominance Proposed Chapterisation Proposed Methodology 1. 2. 3. Indian Pharmaceutical Industry a Snapshot Net Worth 8 Billion Dollars Growth Rate of 8-9% PA. 4th in the World in terms of Volume of Drug Output Exports to nearly 212 countries @ USD 4795.33 million (2005-06) Has an important role to play in promoting public health and Right to Health. Highly technology and knowledge intensive. Indian Pharmaceutical Industry a Snapshot Industry growth highly dependent...

Words: 2852 - Pages: 12

Pharma Industry

...INDIAN PHARMACEUTICAL INDUSTRY – AN OVERVIEW 1. Overview The Indian Pharma industry is one of the fastest growing sectors with approximately 20,000 manufacturing units. The industry that is highly price sensitive ranks thirteenth in the global pharmaceutical market in value terms and fourth in volume terms. The country has tremendous export potential in the areas like custom synthesis, R&D, clinical trials, and Bioinformatics. The industry produces 60,000 finished medicines and roughly 400 bulk drugs, which are used in formulations with about 20% of the manufacturers in the bulk drugs segment. India has approximately 1% share of global pharma industry, which is worth US$406 billion. This implies that there is a huge market waiting to be unfolded. The figure below explains the evolution of Indian pharmaceutical industry: Figure 1: Progress Of Indian Pharmaceutical Industry Source: Pharmabiz.com (Article by Dr. Laxman Prasad) 2. Industry Structure and Size 2.1 Industry Structure The Indian Pharma industry is highly fragmented and can broadly be classified in to two categories: organized and unorganized sector. Figure 2: Revenues of Organised vs. Unorganised Sector Source: Secondary Research The organized sector contributes about 70% of the total revenues and consists of 260 units in both manufacturing as well as formulation segment. This sector can further be divided into Indian and multinational companies. The unorganized sector...

Words: 1530 - Pages: 7

Pharma Industry Analysis

... industry shows an upward trend in its core markets. The industry remains highly valued, has a favourable market position with strong financial make-up and strong earnings growth. Its future potential demand trend is positive and despite increased competition the industry still shows a continuing upward growth momentum. Datamonitor’s9 forecast of the leading 16 pharmaceutical companies for 2001 to 2007 suggests that combined sales will grow at a minimum rate of 5.2 percent based on the potential of their product pipeline. 4. Strategic Issues Facing The Industry The strategic issues shaping the modern pharmaceutical industry are: Industry Consolidation: Merger activity has been intense within the industry in the last decade. Analysts believe that three firms; GlaxoSmithKline, Bristol-Myers Squibb and Merck are likely candidates to be directly involved in the next round of industry consolidation. Eli Lilly and AstraZeneca would make the best partners for GlaxoSmithKline, combining the latter's commercialization strengths with a partner's valuable portfolio and pipeline. A merger with Merck and Johnson may provide a complementary portfolio and a short-term revenue boost, but the long term consequences of such a deal would be a cause of concern if pursued due to the monopolistic consequences such a merger could have. Science and Innovation: Over the last decade the knowledgebase of the pharmaceutical sciences has changed dramatically and continues to change at......

Words: 1706 - Pages: 7

Trend

... net percentage balance greater than 20 in absolute terms, and a ‘slight’ change refers to a net percentage balance of between 5 and 10 in absolute terms. (b) Small businesses are defined as those with annual turnover of less than £1 million; medium-sized corporates are defined as those with annual turnover of between £1 million and £25 million; and large corporates are defined as those with annual turnover of over £25 million. (c) Spreads are over Bank Rate or London interbank offered rate (Libor) for small businesses, and over Libor for medium-sized companies and large corporates. A positive balance indicates that spreads over reference rates have fallen, such that all else being equal it is cheaper for corporates to borrow. Spreads over reference rates on new lending to small businesses remained unchanged in 2015 Q1 according to lenders in the Bank of England’s Credit Conditions Survey (Chart 2.4). Respondents reported that for medium-sized firms spreads had fallen significantly. This continued the trend seen for much of the past two years, where lenders in the survey reported that spreads on loans to small businesses were unchanged, while spreads on loans to medium-sized companies fell significantly, similar to those for large corporates. Pricing on lending to large companies remained favourable, according to survey evidence. Respondents to the Credit Conditions Survey reported that while loan covenants loosened and fees and commissions decreased......

Words: 8959 - Pages: 36

Pharma

... targeted for foreign acquisition. Concerns have been raised that this trend could adversely affect generic drug prices in India. The Ministry of Health wants safeguards built into the Foreign Direct Investment process amid fears that continued foreign acquisitions will adversely affect the domestic industry and push prices up, thereby potentially undermining the government’s efforts to make generic drugs affordable. This could lead to essential medicines becoming more expensive and adversely affecting public health programmes. The need to maintain low prices for essential medicines has been addressed in the government’s draft National Pharmaceutical Pricing Policy (NPPP), released in 2011. The proposed NPPP focuses on the National List of Essential Medicines (NLEM), which is periodically revised. The headline major change is a move from the principle of cost-based pricing to a market-based pricing model. The Department of Pharmaceuticals argues that market-based pricing would result in more transparent and fair pricing, as well as increasing competition in the marketplace. Price regulation will encompass all drugs listed in the NLEM, as well as formulations containing combinations of drugs listed in the NLEM; this will include combinations comprising listed drugs and unlisted drugs. If the NPPP is implemented, around 60% of the drugs currently available in India will come under price control. ENHANCED STRATEGIC INTELLIGENCE Espicom's highly regarded world...

Words: 578 - Pages: 3